Skip Navigation
Department of Health and Human Services www.hhs.gov
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Presentation to Slide Tray Presentation:

Off-Label Use of Atypical Antipsychotics: An Update

Slide: 45 of 47

Conclusions (2 of 3)

The evidence for efficacy of atypical antipsychotics in treating borderline personality disorders is too limited to estimate benefits.

Evidence is insufficient for treatment of Tourette’s syndrome in adults (ages 18–64).

Evidence is stronger that atypical antipsychotics neither increase body weight in patients with anorexia nervosa nor do they reduce substance abuse.

There is little evidence about optimal dosages or durations of treatment in off-label use.